| Rus |  |
Eng |  |
Materials Research Centre
 |
 |
Materials Research Centre is Ukrainian innovation R&D company founded in 1995 by researchers from several institutes of the Ukrainian Academy of Sciences. MRC carries out research in the fields of chemistry, nanomaterials and nanotechnology. MRC in partnering with Carbon-Ukraine company has been specializing in the research and development of 2D nanomaterials MXenes, MAX-phase ceramics, porous carbon nanomaterials CDCs and others. Besides nanotechnological direction MRC has strong engineeering department that provide technology development, engineering design and calculations, manufacturing of non standard experimental equipment, laboratory prototypes, enables technology scaling up to pilot lines. |
 |
 |
|||
 |
 |
 |
 |
||||
 |
 |
 |
 |
||||
 |
 |
 |
 |
||||
 |
 |
 |
 |
 |
 |
 |
|
|
Distinctive excellence of Materials Research Centre is not only its strong scientific potential but also presence of own engineering design group and metal-working manufacturing. This makes possible to provide complete cycle of product manufacturing from its conceiving and engineering design to production and service. MRC has been specializing in the research and development of 2D nanomaterials MXenes, MAX-phase ceramics, porous carbon nanomaterials CDCs and others. Additionally, the company has been engaged in the research into the properties and applications of nano powders of transition metal oxides for solar panels and self-cleaning surfaces. At present the company manufactures electrolytic solar cells from its own materials on the laboratory scale, their voltage and current characteristics being continuously improved. Most of the equipment, employed in the production, namely the furnaces for high temperature treatment of non-organic materials, was designed and manufactured by the company specialists. MRC team comprises highly-qualified experts in different fields of science (chemistry, physics, and material study) and competent designers which allows to achieve significant results both in research and development of alternative energy resources at the world level. One of the major goals of MRC is to promote integration of Ukrainian science in the European and world-wide scientific networks, as well as stabilization of MRC team’s potential, safeguarding highly qualified specialists and maintaining research and technological capacities. MRC participated in several NATO Advanced Study Institutes and Advanced Research Workshops and numerous international conferences, US DoE projects, EC Horizon 2020, Horizon Europe r&d projects and others. One of the specialization areas of the company are: development, design, manufacturing and assembly of non-standard metal arrangements, power equipment, automation systems and multi-purpose power furnaces. MRC has its own manufacturing premises, which is equipped with all the necessary power carriers and comprises: - High temperature furnaces fro specific purposes temperature range 1100 -2000 C. 03142, St. Ak. Omelyana Pritsaka, 3 Kyiv, Ukraine |
|||||||
MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year! Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics. Read the full article here: https://doi.org/10.1039/D4NR04853A.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations to all collaborators with this interesting joint work!
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.
